Easy fix for clinical laboratories for the false-positive defect with the Abbott AxSym total β-hCG test
- 31 May 2004
- journal article
- Published by Elsevier in Clinical Biochemistry
- Vol. 37 (5) , 344-349
- https://doi.org/10.1016/j.clinbiochem.2004.03.001
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Early and late half-life of human chorionic gonadotropin as a predictor of persistent trophoblast after laparoscopic conservative surgery for tubal pregnancyActa Obstetricia et Gynecologica Scandinavica, 2003
- Persistent low levels of human chorionic gonadotropin: A premalignant gestational trophoblastic diseaseAmerican Journal of Obstetrics and Gynecology, 2003
- Heterophile antibody blocking agent to confirm false positive serum human chorionic gonadotropin assayPublished by Wolters Kluwer Health ,2003
- Serum‐hCG: still a problematic markerActa Obstetricia et Gynecologica Scandinavica, 2003
- Falsely elevated human chorionic gonadotropin leading to unnecessary therapy1Obstetrics & Gynecology, 2001
- The influence of naturally occurring heterophilic anti-immunoglobulin antibodies on direct measurement of serum proteins using sandwich ELISAsJournal of Immunological Methods, 2000
- False diagnosis and needless therapy of presumed malignant disease in women with false-positive human chorionic gonadotropin concentrationsThe Lancet, 2000
- Analysis of Hcg: Clinical Applications and Assay RequirementsAnnals of Clinical Biochemistry: International Journal of Laboratory Medicine, 1999
- Phantom hCG and Phantom ChoriocarcinomaGynecologic Oncology, 1998
- Heterophilic Antibodies Remain a Problem for the Immunoassay LaboratoryAmerican Journal of Clinical Pathology, 1997